High demand for OTC cough/cold and pain relief remedies in the US and Canada almost certainly point to consumer health firms reporting strong sales growth in the most recent quarter, with results for the Vicks line the first barometer as Procter & Gamble is first out of the sales-and-earnings gate.
US and Canadian firms marketing OTC drug and dietary supplement and reporting results for the October-December period also will be offering additional signals on planned spinoffs of their consumer health business, in the case of Johnson &
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?